SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is surging amidst escalating Middle East tensions and concerns over restricted oil flows through the Strait of Hormuz, sparking community speculation on a prolonged energy shock versus an eventual price correction.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending due to escalating Middle East tensions, with Iranian strikes on oil infrastructure and the effective closure of the Strait of Hormuz fueling expectations of a massive oil price surge. The community is actively debating if this geopolitical risk premium signals a sustained energy rally or a fleeting market panic, impacting broader inflation concerns.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending due to its recent Q4 earnings report, which sparked polarized community debate following a headline revenue miss attributed to one-time accounting adjustments. While some investors express concern over revenue recognition, many view the reported strong annual growth, record cash balance, and new $25M share repurchase program as robust bullish indicators, labeling the stock an "absolute bargain" amid a perceived market overreaction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is generating intense anticipation around its pivotal Phase 3 REGAL trial results for GPS, an immunotherapy for AML, with community discussions highlighting potential for "curative outcomes" and a massive market opportunity, fueling widespread speculation of an imminent Big Pharma buyout as the CEO's recent communications are seen as highly bullish signals.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as its utility gains traction through major integrations with Sui and Cardano, alongside a notable partnership with the US Commerce Department to publish economic data on-chain. The community is buzzing about its position as a vital Real World Asset (RWA) oracle, often comparing its fundamental value against meme tokens, further fueled by its newly announced token buyback program.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility as escalating geopolitical tensions in the Middle East and mixed sentiment following recent semiconductor earnings reports drive sharp market swings, leading the community to intensely debate aggressive 'buy the dip' opportunities versus predictions of further downside.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending due to consistent inflows into its spot ETFs and favorable regulatory developments, such as Japan classifying it as a financial asset, signaling increased institutional interest. The community remains divided, with many actively accumulating during price dips in anticipation of a rally, while others voice strong skepticism regarding its underlying value and potential for dilution.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending following its definitive agreement to acquire Warner Bros. Discovery, a move viewed by bulls as creating a formidable global streaming and media giant under David Ellison's strategic vision, while bears raise significant concerns over the massive debt burden leading to recent credit downgrades.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending due to its strategic workforce reductions despite strong earnings, sparking community debate over efficiency versus weakness, while simultaneously making significant moves into cryptocurrency ETFs and custody services, signaling a bold pivot into digital assets amidst a recovering M&A market.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending as escalating Middle East tensions drive global oil prices higher, yet the community is actively discussing its puzzling lag behind surging crude and widely anticipating a significant catch-up rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The partnership makes Medirom the operator for World ID verification across Japan.</li><li>Its rollout will use Medirom’s 300 locations, along with flagship and pop-up sites, to scale quickly.</li><li>Investors reacted positively to the prospect of a new, recurring revenue stream beyond wellness.</li></ul>Shares of Medirom Healthcare Technologies Inc. (MRM) jumped about 10% in after-hours trading on Friday after the company announced a partnership tied to OpenAI CEO Sam Altman’s World project, positioning Medirom as a key operator in Japan’s rollout of “Proof of Human” verification technology.<h2 class="st-heading-2">Medirom Picked To Operate World ID Locations In Japan</h2>Medirom said it has entered into a master service agreement with Tools for Humanity and the World Foundation to operate World’s “Proof of Human” verification locations across Japan. World is a biometric identity project co-created by Sam Altman and Alex Blania that aims to help users prove they are human online without revealing personal identity.Under the agreement, Medirom will be responsible for running verification sites using World’s technology, including the deployment of Orb devices that confirm humanness through privacy-preserving biometric methods.<h2 class="st-heading-2">Nationwide Rollout&nbsp;</h2>Medirom plans to use its nationwide footprint of roughly 300 locations to accelerate deployment. The company said it will also establish flagship verification sites and temporary pop-up locations in commercial and public spaces, supported by a newly formed internal task force dedicated to the project.The company expects the initiative to generate revenue over time through operating fees and related services as adoption scales.<h2 class="st-heading-2">‘Proof of Human’ Gains Focus Amid AI Boom</h2><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/sam-altman-world-eye-scanning-startup-uk/chlEkYsRby1">World project was created</a> to address growing concerns that advances in AI are making it harder to distinguish humans from bots online. The project uses blockchain-based infrastructure to provide users with an anonymous World ID that can be used across participating platforms.Tools for Humanity, which led the initial development of the World project, said Japan’s high level of technology adoption makes it a key market for expanding digital identity infrastructure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:974/141;" src="https://news.stocktwits-cdn.com/mrm_ss_png_f13ca655da.webp" alt="mrm ss.png" width="974" height="141"><figcaption>MRM sentiment and message volume as of December 26| Source: Stocktwits</figcaption></figure>One user said they can see the stock “rallying” next week.<stembedurl>https://stocktwits.com/squarellim/message/640209408</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the MEDIROM Healthcare Technologies logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Medirom Stock Jumps 10% After Hours On Deal To Run Sam Altman’s World ‘Proof Of Human’ Sites In Japan

The deal positions Medirom at the center of Japan’s push to deploy human-verification infrastructure as AI adoption accelerates.

Equity

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 2.8% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Stock Price Up 1% - Should You Buy?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1% Higher - Here's Why...

MEDIROM Healthcare Technologies (NYSE:MRM) Trading 1.6% Higher - What's Next?

MEDIROM Healthcare Technologies (NYSE:MRM) Trading Up 1.6% - Should You Buy...

Shares of Medirom Healthcare Technologies surged over 250% in premarket trading on Friday after the Tokyo-based wellness and healthtech company announced a partnership with World, the “proof of human” protocol co-founded by OpenAI’s Sam Altman and Alex Blania of Tools for Humanity.Medirom said it will install World ID’s Orb authentication devices across 100 of its Re.Ra.Ku relaxation studios in Japan this month, expanding to 200 locations nationwide. The rollout represents the largest Orb deployment in Japan so far, aimed at providing broad access to a system that verifies individuals’ “humanness” without revealing their identity.The Orb, an advanced imaging device, issues a World ID once verification is complete, which is stored in the World App for use across compatible services. Medirom said its integration of the devices underscores its push to fuse healthcare with technology while accelerating World ID adoption in Japan.The company operates over 300 wellness salons under various brands, including Re.Ra.Ku, Spa Re.Ra.Ku, and Bell Epoc, and also develops digital health solutions, including the Lav training app and the Mother Bracelet, a battery-free smart tracker used in industries from caregiving to construction.On Stocktwits, retail sentiment for Medirom was ‘extremely bullish’ amid ‘extremely high’ message volume.Some retail traders speculated on sharp price targets for Medirom, with one suggesting the stock could open at around $7, while another said it might climb to $10 during the session.<stembedurl>https://stocktwits.com/madstocks123/message/630074517</stembedurl><stembedurl>https://stocktwits.com/HellenicRenegade/message/630087145</stembedurl><a href="https://stocktwits.com/symbol/MRM">Medirom’s stock</a> has risen nearly 41% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is Medirom Healthcare Technologies Stock Surging Over 250% Premarket Today?

The surge followed news that Medirom will deploy Sam Altman’s World ID Orb devices across its Re.Ra.Ku studios in Japan.

Medirom Healthcare Technologies ($MRM) ADR shares were down 12% on Monday, even as the Japan-based wellness salon operator announced a series A equity raise by its subsidiary.Medirom subsidiary Medirom Mother Labs Inc. has raised an aggregate total of 260.3 million yen, or about $1.7 million, at a pre-money equity valuation of JPY9 billion, or about $58.6 million in its Series A equity financing, the company said in a statement.The firm noted NFES Technologies Inc. was the lead investor in the financing round, along with several other public companies in Japan, including M3 Inc. and Elematec Corp. Certain individual investors also participated in the round. Medirom Mother Labs has closed financings with six investors to date and hopes to complete this round by December 31.“We are very excited that our Medirom Mother Labs subsidiary has received such significant validation from strategic partners as our lead investor NFES Technologies Inc.,” Kouji Eguchi, Medirom’s CEO, said in a statement. “The pre-money valuation of 9 billion yen is approximately multiples of Medirom’s current NASDAQ listing market capitalization…further validates our technology, business model, and growth potential.” Retail chatter on Stocktwits indicated a mixed take on the stock.<stembedurl>https://stocktwits.com/HumbleTrader187/message/596459081</stembedurl><stembedurl>https://stocktwits.com/biff1/message/596382806</stembedurl><stembedurl>https://stocktwits.com/Z_interceptor/message/596439765</stembedurl>Medirom operates over 300 wellness salons across Japan under its Re.Ra.Ku brand.Shares of the firm are down 80% year-to-date.(Calculations based on an exchange rate of JPY153.64 to $1)For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medirom Healthcare Stock Dips On Series A Equity Raise: Retail’s Divided

 NFES Technologies Inc. is the lead investor in the latest financing round.

MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi on July 13, 2000 and is headquartered in Tokyo, Japan.

MRM
MEDIROM Healthcare Technologies Inc - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MRM News

MRMMEDIROM Healthcare Technologies Inc - ADR